Contribution of selected gene mutations to resistance in clinical isolates of vancomycin-intermediate Staphylococcus aureus.
about
Evolution of resistance to a last-resort antibiotic in Staphylococcus aureus via bacterial competitionSystematic Review and Meta-Analysis of the Epidemiology of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus IsolatesMechanisms of vancomycin resistance in Staphylococcus aureusStructure, Bioactivity, and Resistance Mechanism of Streptomonomicin, an Unusual Lasso Peptide from an Understudied Halophilic ActinomyceteIntermediate-type vancomycin resistance (VISA) in genetically-distinct Staphylococcus aureus isolates is linked to specific, reversible metabolic alterations.Dissecting vancomycin-intermediate resistance in staphylococcus aureus using genome-wide association.Community-associated methicillin-resistant Staphylococcus aureus case studies.Exposure of Staphylococcus aureus to subinhibitory concentrations of β-lactam antibiotics induces heterogeneous vancomycin-intermediate Staphylococcus aureusEvolution of community- and healthcare-associated methicillin-resistant Staphylococcus aureus.Production of capsular polysaccharide does not influence Staphylococcus aureus vancomycin susceptibilityReversible antibiotic tolerance induced in Staphylococcus aureus by concurrent drug exposure.[Resistance to "last resort" antibiotics in Gram-positive cocci: The post-vancomycin era].The Eukaryotic-Like Ser/Thr Kinase PrkC Regulates the Essential WalRK Two-Component System in Bacillus subtilisEvolving resistance among Gram-positive pathogensClinical and Microbiological Characteristics of Heteroresistant and Vancomycin-Intermediate Staphylococcus aureus from Bloodstream Infections in a Brazilian Teaching HospitalAlternative mutational pathways to intermediate resistance to vancomycin in methicillin-resistant Staphylococcus aureus.Decreased vancomycin susceptibility in Staphylococcus aureus caused by IS256 tempering of WalKR expression.Novel Mutation Sites in the Development of Vancomycin- Intermediate Resistance in Staphylococcus aureus.Genome sequence-based discriminator for vancomycin-intermediate Staphylococcus aureus.Genetic engineering of a temperate phage-based delivery system for CRISPR/Cas9 antimicrobials against Staphylococcus aureus.Vancomycin therapeutics and monitoring: a contemporary approach.The future of antimicrobial therapy in the era of antibiotic resistance in cystic fibrosis pulmonary infection.Novel Observations in 11 Heteroresistant Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus Strains from South India.Reduced Vancomycin Susceptibility of Methicillin-Susceptible Staphylococcus aureus Has No Significant Impact on Mortality but Results in an Increase in Complicated Infection.Phenotypic and genomic comparisons of highly vancomycin-resistant Staphylococcus aureus strains developed from multiple clinical MRSA strains by in vitro mutagenesis.Multiple pathways of cross-resistance to glycopeptides and daptomycin in persistent MRSA bacteraemia.Generation of a vancomycin-intermediate Staphylococcus aureus (VISA) strain by two amino acid exchanges in VraS.VraR Binding to the Promoter Region of agr Inhibits Its Function in Vancomycin-Intermediate Staphylococcus aureus (VISA) and Heterogeneous VISA.Reduced vancomycin susceptibility in porcine ST9 MRSA isolates.Daptomycin Resistance in Clinical MRSA Strains Is Associated with a High Biological Fitness Cost.Induction of Immunosuppressive CD8+CD25+FOXP3+ Regulatory T Cells by Suboptimal Stimulation with Staphylococcal Enterotoxin C1.Actinorhodin is a redox-active antibiotic with a complex mode of action against Gram-positive cells.Metabolic Mitigation of Staphylococcus aureus Vancomycin Intermediate-Level Susceptibility.Novel single-nucleotide variations associated with vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.Distribution of the Most Prevalent Spa Types among Clinical Isolates of Methicillin-Resistant and -Susceptible Staphylococcus aureus around the World: A Review.
P2860
Q24490083-DF50FC54-D212-45DE-8E1B-108BFF88D1CBQ26796560-3EF0D250-6C35-4E57-A6E0-3A81D5FE5B68Q26829312-B51B0F70-B51C-472E-B483-66025F2FA340Q27644318-67332145-809A-4D84-AE6F-E10B7E0A410AQ33591402-73402B23-3ED2-41FE-8992-BF29863ABD19Q33696380-C771E05C-7FED-4F7C-810D-B1A10C9FC507Q33792021-446BB7DC-095C-409A-A51A-1759EEF4954EQ34057324-30F66123-25A7-427D-8990-0ADCFAFC00FAQ34343212-3887EA28-778B-42CE-8337-7F29550BBBEDQ34632683-D519B5F0-7CF7-40B2-A23A-B17E48FF3749Q35038242-AFE333DC-C514-4880-9016-6BF9C7B9D006Q35619094-63F6A773-C1E1-48CC-A0F1-88F7E8801706Q35671883-D79DC1C6-20F0-456E-B4B2-AB2E26554F05Q35999912-89184511-121F-46BD-941B-26A43B66608BQ36116970-3DB8DC79-3FD2-4A3C-9332-D2410D40AE8FQ36882486-E2AFA82B-1F56-4DE0-B872-156105F2203BQ36969754-96F92F60-5CB5-4DF1-B587-3ADFCB66DC33Q37575024-89E25700-59DD-4528-82F4-366A8FCA36B3Q37643403-AF73848B-62D2-470A-847D-E57F7CF22EABQ37712935-17F1F700-FD22-40CA-AEE4-63AAEFD6DBC0Q38062923-F699C4FA-18BF-4883-A9E1-BA6B9031E8C7Q38130513-27AD174E-FF68-4A0B-A3FB-E31D695EECE9Q39743944-200BAD8E-9A3C-4F1F-8551-C0DDC88B611AQ40200466-54CB6F52-F11F-4844-BF59-7744D528F346Q40896611-DE10DFD5-F4E3-4720-BB1D-A5601FB819B9Q41087225-259DC036-1BD4-43BF-817A-C3FF8DD03375Q42202739-8F8A7FF9-156C-4777-BF1F-C8BBBD763019Q42358800-D2DEEE4C-E45B-4946-8A69-3A6D0D674AE4Q42905367-07DE91AA-A89C-480D-AE74-1C18153D4897Q47116570-A1822365-D723-4458-A1D9-B2A2E8D5B523Q47252494-FA4AE266-3C73-46C3-910A-3454DDDED061Q47804224-409D6D20-F186-482B-B946-252FC201847EQ50132676-E16CE420-3C73-49DF-B142-6F29AF063270Q50195416-FE194216-8C8C-4DD1-92FA-8978234258C2Q50327973-0B1D0A02-B2AC-4E04-BA41-4D0C125EC2E3
P2860
Contribution of selected gene mutations to resistance in clinical isolates of vancomycin-intermediate Staphylococcus aureus.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Contribution of selected gene ...... mediate Staphylococcus aureus.
@en
type
label
Contribution of selected gene ...... mediate Staphylococcus aureus.
@en
prefLabel
Contribution of selected gene ...... mediate Staphylococcus aureus.
@en
P2093
P2860
P356
P1476
Contribution of selected gene ...... mediate Staphylococcus aureus.
@en
P2093
Anne-Catrin Uhlemann
Cory Hafer
Franklin D Lowy
John Kornblum
P2860
P304
P356
10.1128/AAC.01139-12
P407
P577
2012-09-04T00:00:00Z